SV Life Sciences Fund V

SVLSFV closed in June 2010 with total commitments of $513m (plus $11 million of co-investments committed by partners and individuals affiliated with SVLS). As at 31 March 2010 the Fund had invested $10.5m in two portfolio companies.

To go to individual portfolio companies websites please click on company logo.

Bicycle Therapeutics: UK

First investment 2009 – Seed

Developing a platform technology that may enable the creation of a new generation of biotherapeutics.

---

Broadlane: US

First investment 2009 – Development

Group Purchasing Organisation (’GPO’) focused on the acute health care sector.

---

Catabasis Pharmaceuticals: US

First Investment 2010 – Start up

Developing therapeutics of the treatment of inflammatory and metabolic diseases.

---

The Corner Pharmacy: US

First investment 2010 - Development

An owner and operator of hospital-based retail pharmacies through joint ventures with hospital systems.

---